Bausch Health (BHC) ebitda was $3.2B in FY2025 (+9% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$3.2B
+9%
2024
$3.0B
+26%
2023
$2.4B
+20%
2022
$2.0B
-7%
2021
$2.1B
-19%
2020
$2.6B
+31%
2019
$2.0B
+269%
2018
$544M
-82%
2017
$3.1B
+19%
2016
$2.6B
-42%
2015
$4.5B
+10%
2014
$4.1B
+93%
2013
$2.1B
+51%
2012
$1.4B
+27%
2011
$1.1B
+188%
2010
$383M
+5%
2009
$366M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$1.1B
Q1 2026
-$603M
Q4 2025
$848M
Q3 2025
$968M
Q2 2025
$797M
Q1 2025
$624M
Q4 2024
$908M
Q3 2024
$678M
Q2 2024
$743M
Q1 2024
$634M
Q4 2023
$720M
Q3 2023
$344M
Source: BHC on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.